Cost of cerivastatin in cost-effectiveness study.
Chung
K C
KC
Pomerantz
K
K
Harrison
B
B
D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics* / Q000627:therapeutic use; D018803:Models, Economic; D009203:Myocardial Infarction / Q000188:drug therapy; D011725:Pyridines / Q000191:economics* / Q000627:therapeutic use
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011725:Pyridines; C086276:cerivastatin